Ekso Bionics to Report Second Quarter 2024 Financial Results on July 29, 2024
Ekso Bionics Holdings, Inc. (EKSO), a leader in exoskeleton technology for medical and industrial use, has announced its plans to release financial and business results for the second quarter of 2024. The results will be made public after the close of trading on Monday, July 29, 2024. Following the release, management will host a conference call at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial results and recent business developments.
Investors can access the live webcast of the event through the "Investors" section of the company's website. For those preferring to listen via phone, domestic callers can dial 877-407-3036, while international callers should use 201-378-4919. A replay of the webcast will be available on the company's website for one month after the call.
- None.
- None.
SAN RAFAEL, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the second quarter 2024 after the close of trading on Monday, July 29, 2024. Management will host a conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial results and recent business developments.
A live webcast of the event will be available in the “Investors” section of the Company’s website at www.eksobionics.com, or by clicking here. Investors interested in listening to the conference call may do so by dialing 877-407-3036 for domestic callers or 201-378-4919 for international callers.
A webcast replay will also be available on the Company’s website for one month following the completion of the call.
About Ekso Bionics®
Ekso Bionics® is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance and mobility across medical and industrial applications. Founded in 2005, the Company continues to build upon its industry-leading expertise to design some of the most cutting-edge, innovative wearable robots available on the market. Ekso Bionics is the only known exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe. The Company is headquartered in the San Francisco Bay Area and is listed on the Nasdaq Capital Market under the symbol “EKSO.” For more information, visit: www.eksobionics.com or follow @EksoBionics on X.
Contact:
David Carey
212-867-1768
investors@eksobionics.com
FAQ
When will Ekso Bionics (EKSO) release its Q2 2024 financial results?
What time is Ekso Bionics' (EKSO) Q2 2024 earnings call scheduled for?
How can investors access Ekso Bionics' (EKSO) Q2 2024 earnings call?
Will there be a replay available for Ekso Bionics' (EKSO) Q2 2024 earnings call?
